newsfilter
← Latest News
ACCESS Newswire·

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and preferential lung enrichment